DatabasE Study For patIeNts trEated with GLP-1RA in Japan

DatabasE Study For patIeNts trEated with GLP-1RA in Japan - DEFINE-G

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045687

Enrollment

3800

Registered

2021-10-06

Start date

2021-07-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Primary Outcome 1. Age: 18 y.o. or older 2. Those with type 2 diabetes mellitus. 3. Those with prescription of GLP-1 Receptor Agonists between December 1, 2015 to March 31, 2021

Exclusion criteria

Exclusion criteria: Primary Outcome 1. Those with type 1 diabetes mellitus. 2. Those with history of gestational diabetes between 360 days before the index date and 360 days after the index date

Design outcomes

Primary

Measure	Time frame
Annual descriptions of numbers and clinical characteristics of patients with type 2 diabetes treated with GLP-1 receptor agonists between 2015 -2021.	—

Countries

Japan

Contacts

Public ContactMitsuru Ohsugi

National Center for Global Health and Medicine Diabetes and Metabolism Information Center

jdreams-info@hosp.ncgm.go.jp03-3202-7181

Outcome results